Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    2333868 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Safety and Dose Finding Study of Xigris in Hemodialysis Patients
Condition: End Stage Renal Disease
Intervention: Drug: Drotrecogin alfa activated

Indicates status has not been verified in more than two years